Rowan E. Miller
London, ENG, United Kingdom
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 61 publications
Phase Ib trial of SL-172154, a bispecific CD47 inhibitor and CD40 agonist Fc-fusion protein, in combination with mirvetuximab soravtansine or pegylated liposomal doxorubicin in patients with platinum-resistant ovarian cancer.
Journal: British journal of cancer
Published: September 20, 2025
P-POSSUM Falls Short: Predicting Morbidity in Ovarian Cancer (OC) Cytoreductive Surgery.
Journal: Cancers
Published: September 11, 2025
Study protocol for Adaptive ChemoTherapy for Ovarian cancer (ACTOv): a multicentre phase II randomised controlled trial to evaluate the efficacy of adaptive therapy (AT) with carboplatin, based on changes in CA125, in patients with relapsed platinum-sensitive high-grade serous or high-grade endometrioid ovarian cancer.
Journal: BMJ open
Published: January 14, 2025
Controversies and clinical unknowns in the use of PARP inhibitors in ovarian cancer.
Journal: Therapeutic advances in medical oncology
Published: January 13, 2025
Current practices for the management of advanced high-grade epithelial ovarian cancer in the UK: OC-NOW survey (2023).
Journal: Future oncology (London, England)
Published: November 25, 2024
The DNA-PK inhibitor AZD7648 alone or combined with pegylated liposomal doxorubicin in patients with advanced cancer: results of a first-in-human Phase I/IIa study.
Journal: British journal of cancer
Published: November 04, 2024
Patient-reported outcomes from the MIRASOL trial evaluating mirvetuximab soravtansine versus chemotherapy in patients with folate receptor α-positive, platinum-resistant ovarian cancer: a randomised, open-label, phase 3 trial.
Journal: The Lancet. Oncology
Published: September 06, 2024
Real World Outcomes in Patients With Recurrent, Advanced, or Metastatic Endometrial Cancer Treated With Lenvatinib Plus Pembrolizumab.
Journal: Clinical oncology (Royal College of Radiologists (Great Britain))
Published: July 24, 2024
Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London.
Journal: Cancers
Published: July 16, 2024
The impact of inter-cycle treatment delays on 5-year all-cause mortality in early-stage breast cancer: A retrospective cohort study.
Journal: European journal of cancer (Oxford, England : 1990)
Published: May 17, 2024
A multicenter retrospective study to assess feasibility, safety and efficacy of first-line carboplatin-paclitaxel versus carboplatin monotherapy in a frail, elderly epithelial ovarian cancer population☆.
Journal: International journal of gynecological cancer : official journal of the International Gynecological Cancer Society
Published: February 12, 2024
Last Updated: 09/26/2026